NCT03289650View on ClinicalTrials.gov

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

February 23, 2021

Study Completion Date

February 23, 2021

Conditions
End Stage Renal DiseaseRejection of Renal Transplant
Interventions
DRUG

Tacrolimus

immunosuppressive agent tacrolimus, given twice-daily

DRUG

Tacrolimus Extended Release Oral Tablet [Envarsus]

immunosuppressive agent extended-release tacrolimus, given once daily

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Lorenzo Gallon

OTHER

NCT03289650 - Extended Release Tacrolimus vs. Twice-Daily Tacrolimus | Biotech Hunter | Biotech Hunter